Similar articles

• Editorial: Prostaglandins, hypercalcemia and cancer.

  Tashjian AH Jr. Tashjian AH Jr. N Engl J Med. 1975 Dec 18;293(25):1317-8. doi: 10.1056/NEJM197512182932511. N Engl J Med. 1975. PMID: 1186828 No abstract available.
• [Cyclic adenosine monophosphate and prostaglandins in oncology].

  Bershteĭn LM, Dil'man VM. Bershteĭn LM, et al. Vopr Onkol. 1974;20(3):105-20. Vopr Onkol. 1974. PMID: 4373912 Review. Russian. No abstract available.
• [Significance of prostaglandins for tumor growth and tumor symptoms].

  Peskar BM. Peskar BM. Med Klin. 1981 Jan 2;76(1):11-4. Med Klin. 1981. PMID: 7019649 Review. German. No abstract available.
• [Physiological and pharmacological actions of prostaglandins and related substances on mineral metabolism].

  Komori T, Morii H. Komori T, et al. Nihon Rinsho. 1985 Mar;43(3):537-43. Nihon Rinsho. 1985. PMID: 2989585 Review. Japanese. No abstract available.
• Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.

  Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT Jr, Oates JA. Seyberth HW, et al. N Engl J Med. 1975 Dec 18;293(25):1278-83. doi: 10.1056/NEJM197512182932502. N Engl J Med. 1975. PMID: 1186822